Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases

Area of Science:

• Oncology
• Neuroscience
• Pharmacology

Background:

• Brain metastases are the most common brain tumors and are associated with a poor prognosis and high mortality.
• Current treatments like surgery and radiotherapy have limitations, and effective systemic therapies are lacking, leading to inevitable recurrences.
• Physiological factors (e.g., heterogeneous permeability, high interstitial pressure) and molecular adaptations within the brain microenvironment hinder drug efficacy.

Purpose of the Study:

• To discuss the molecular and physiological factors contributing to the resistance of brain metastases to therapies.
• To review emerging therapeutic strategies for treating brain metastases.
• To highlight the need for novel delivery strategies to achieve uniform drug uptake.

Main Methods:

• Literature review of factors limiting intracranial drug efficacy.
• Discussion of molecular mechanisms of resistance, including receptor tyrosine kinases like HER3.
• Overview of novel therapeutic approaches such as PI3K inhibitors, immunotherapies, nanomedicines, and focused ultrasound.

Main Results:

• Brain metastases exhibit complex tumor-stroma-neural cross-talk, driving resistance.
• Specific molecular pathways, including HER3 activation, are implicated in treatment failure.
• Emerging strategies show promise in overcoming delivery barriers and resistance mechanisms.

Conclusions:

• Addressing the unique physiological and molecular challenges of the brain microenvironment is crucial for effective brain metastasis treatment.
• Novel therapeutic strategies, including targeted agents and advanced drug delivery systems, offer new hope.
• Further research into overcoming drug resistance and improving drug delivery is essential for improving outcomes.